Inhalers for COPD provide steroids, bronchodilators, or combination drugs. The three types differ in the mechanism by which the medication is inhaled and have different instructions for use.

Do not initiate in rapidly or acutely deteriorating COPD or asthma. Not for use with other long-acting β 2-agonists. Do not exceed recommended dose. Prescribe a short-acting, inhaled β 2-agonist ...

Approved yesterday by the FDA, Trelegy Ellipta is the first ever daily single-inhaler to combine a triple therapy for COPD, and could ... GSK's newer double therapy, Breo Ellipta, which is slowly ...

GlaxoSmithKline has filed its new COPD triple therapy with ... could help erase the slow start of Breo and Anoro[/caption] Fluticasone furoate is an inhaled corticosteroid (ICS), umeclidinium ...

DOI: 10.1136/bmj-2024-080409 Meng-Ting Wang et al, Environmentally friendly inhaler regimens for COPD, BMJ (2024). DOI: 10.1136/bmj.q2825 ...

Companies like AstraZeneca and GSK, which have high-revenue-generating inhalers for asthma and chronic obstructive pulmonary disorder (COPD ... followed by Relvar/Breo Ellipta and Seretide ...

From being able to address patient questions to how this could impact your local pharmacy, there are still a lot of moving parts.